Search Results - "Vallow, LA"

Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer by Vicini, FA, Cecchini, RS, White, JR, Julian, TB, Arthur, DW, Rabinovitch, RA, Kuske, RR, Parda, DS, Ganz, PA, Scheier, MF, Winter, KA, Paik, S, Kuerer, HM, Vallow, LA, Pierce, LJ, Mamounas, EP, Costantino, JP, Bear, HD, Germaine, I, Gustafson, G, Grossheim, L, Petersen, IA, Hudes, RS, Curran, WJ, Wolmark, N

“…Background: Conventional WBI after lumpectomy for early-stage breast cancer decreases ipsilateral breast tumor recurrence (IBTR), yielding comparable results…”
Get full text

Abstract P2-04-02: Immunomodulatory effects of entinostat on PD-L1 and MHC class I and II in different subtypes of breast cancer by Chumsri, S, Necela, BM, Ordentlich, P, Advani, P, Moreno-Aspitia, A, McLaughlin, SA, Geiger, X, McDonough, M, Vallow, LA, Perez, EA, Thompson, EA

“…Background: Targeting immune checkpoint programmed death receptor 1 (PD-1)/PD-L1 pathway has shown promising clinical activity with some preliminary…”
Get full text

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy by Ganz, PA, Cecchini, RS, Julian, TB, Margolese, RG, Costantino, JP, Vallow, LA, Albain, KS, Whitworth, PW, Cianfrocca, ME, Brufsky, A, Gross, HM, Soori, GS, Hopkins, JO, Fehrenbacher, L, Sturtz, K, Wozniak, TF, Seay, TE, Mamounas, EP, Wolmark, N

“…Background The clinical results of NSABP B-35, phase III trial comparing 1 mg/day A to 20 mg/day tam, each given for 5 years, were reported at ASCO 2015. B-35…”
Get full text

MRI findings in women with triple negative breast cancer by Hines, SL, McLaughlin, SA, Vallow, LA

“…Abstract #4014 Background
 Preoperative magnetic resonance imaging (MRI) of the breasts in women with breast cancer (BC) has improved the detection of occult…”
Get full text

The utility of preoperative breast magnetic resonance imaging in invasive breast cancer according to HER2 status by McLaughlin, SA, Vallow, LA, Hines, SL, Tan, W

“…Abstract #4020 Background: HER2 positive (HER2+) breast cancer accounts for 20% of all breast cancer and is an independent adverse prognostic factor. Breast…”
Get full text